AA
AGL icon

ACT Advisors’s Agilon Health AGL Stock Holding History

ACT Advisors’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-984
Closed -$16.9K – 79
2025
Q4 		$16.9K Buy
+984
New +$19.1K 0.01% 64

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

ACT Advisors's AGL Position: Q1 2026 in Review

ACT Advisors sold out of Agilon Health (AGL) in Q1 2026, closing a stake of 984 shares — an estimated $16.9K sold.

ACT Advisors first reported a position in AGL in Q4 2025 and held it in 1 quarter. The position peaked at $16.9K in Q4 2025. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • ACT Advisors reported no remaining Agilon Health position as of Q1 2026 after selling out during the quarter.
  • ACT Advisors sold 984 Agilon Health shares in Q1 2026, an estimated $16.9K.
  • ACT Advisors first reported a position in Agilon Health in Q4 2025 and held it in 1 quarter.
  • ACT Advisors's Agilon Health position peaked at $16.9K in Q4 2025.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on ACT Advisors's 13F filing for Q1 2026, filed 14 Apr 2026.